Stay updated on Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page
- Check6 days agoChange DetectedA new revision tag 'Revision: v3.6.6' was added and the previous 'Revision: v3.6.5' tag was removed. This indicates an update to the page's version.SummaryDifference0.0%

- Check13 days agoChange Detected2018 ( U.S. NIH Grant/Contract ) was added to the study's identifiers, signaling NIH funding attribution. This addition adds funding-related metadata to the record without changing the study's design or reported results.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page's revision label changed from v3.6.4 to v3.6.5, signaling a small update to the Study Details page.SummaryDifference0.0%

- Check34 days agoChange DetectedThe study record now includes an EU CTIS trial number (2024-514479-16-00) and recent update dates, representing regulatory identifiers and the latest data refresh for the record.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a minor software version update on the page.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page’s Revision identifier was updated from v3.6.2 to v3.6.3, reflecting a newer version of the page. This appears to be an internal versioning update rather than a change to the study details or user-facing content.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.